ArticleF1000Research2026
HUCSR-Net: Automated Pulmonary Embolism Detection Using 3D Deep Learning.
Article in F1000Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary embolism (PE) remains a leading cause of cardiovascular mortality and a major diagnostic challenge in emergency settings worldwide. Although computed tomography pulmonary angiography (CTPA) is the reference standard, its interpretation is time-consuming, subject to inter-observer variability, and dependent on subspecialist expertise, potentially delaying life-saving treatment. Methods: We developed and validated HUCSR-Net, a fully automated 3D convolutional neural network for PE detection using 128,484 imaging studies from 86 patients at Hospital Universitario Clínica San Rafael (Bogotá, Colombia). A modern R(2 + 1)D-18 architecture, pre-trained on Kinetics-400, was adapted to single-channel input by averaging the RGB weights of the first convolutional layer. The classification head was replaced by a dropout layer (p = 0.6) followed by a single linear unit. The model was trained from scratch with patient-level 5-fold cross-validation, using AdamW optimiser and binary cross-entropy with logits loss. All experiments were conducted on a workstation equipped with an NVIDIA GeForce RTX 5070 Ti GPU (16 GB VRAM) and an AMD Ryzen 9 9950X processor. Performance was evaluated by the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and F1-score. Results: After several experiments, the optimal model was obtained with a validation AUC of 0.7026, sensitivity of 0.8592, specificity of 0.2673, precision of 0.4519, and F1 score of 0.592. The Matthews correlation coefficient was 0.1515, and the area under the precision-recall curve was 0.5907, confirming solid discriminatory performance despite the limited size of the cohort and validation losses of 0.7989, respectively. Conclusions: A deep 3D convolutional network trained from scratch on a modest single-centre cohort can achieve diagnostic performance comparable to published multi-thousand-patient studies relying on large public datasets. These results demonstrate the feasibility of clinically useful automated PE detection in resource-constrained settings and support the integration of such systems as decision-support tools for radiologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.